IN2014DN06739A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN06739A IN2014DN06739A IN6739DEN2014A IN2014DN06739A IN 2014DN06739 A IN2014DN06739 A IN 2014DN06739A IN 6739DEN2014 A IN6739DEN2014 A IN 6739DEN2014A IN 2014DN06739 A IN2014DN06739 A IN 2014DN06739A
- Authority
- IN
- India
- Prior art keywords
- treatment
- cryotherapy
- lesions
- sequential
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
The invention relates to the treatment of actinic keratosis (AK) lesions using sequential cryotherapy and field treatment with ingenol mebutate (e.g. PEP005 Gel).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261591093P | 2012-01-26 | 2012-01-26 | |
US201361753779P | 2013-01-17 | 2013-01-17 | |
PCT/EP2013/051435 WO2013110756A1 (en) | 2012-01-26 | 2013-01-25 | Ingenol mebutate in combination with cryotherapy for the treatment of actinic keratosis |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN06739A true IN2014DN06739A (en) | 2015-05-22 |
Family
ID=47681847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6739DEN2014 IN2014DN06739A (en) | 2012-01-26 | 2013-01-25 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20150025139A1 (en) |
EP (1) | EP2806869A1 (en) |
IN (1) | IN2014DN06739A (en) |
WO (1) | WO2013110756A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180104503A1 (en) | 2016-10-15 | 2018-04-19 | Michelle Wirtz | Cold atmospheric plasma treatment of actinic keratosis and non-melanoma skin cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130091647A (en) * | 2010-04-16 | 2013-08-19 | 레오 파마 에이/에스 | Crystalline ingenol mebutate |
-
2013
- 2013-01-25 WO PCT/EP2013/051435 patent/WO2013110756A1/en active Application Filing
- 2013-01-25 IN IN6739DEN2014 patent/IN2014DN06739A/en unknown
- 2013-01-25 EP EP13703343.7A patent/EP2806869A1/en not_active Withdrawn
-
2014
- 2014-07-28 US US14/444,787 patent/US20150025139A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150025139A1 (en) | 2015-01-22 |
EP2806869A1 (en) | 2014-12-03 |
WO2013110756A1 (en) | 2013-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016003129A (en) | Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1. | |
HK1210957A1 (en) | Effluz inhibitor compositions and methods of treatment using the same | |
CL2015003704A1 (en) | Peptides and peptidomimetics in combination uses and treatments for the subpopulation of cancer patients | |
EP2995263A4 (en) | Endoscopic treatment instrument | |
MX2022011225A (en) | Pharmaceutical formulations of a hif hydroxylase inhibitor. | |
EP3037031A4 (en) | Endoscope and endoscope system | |
EP2979657A4 (en) | Medical instrument and medical system | |
EP3050492A4 (en) | Light source unit and endoscope device | |
EP2971019A4 (en) | Propagating an organism and related methods and compositions | |
EP2995262A4 (en) | Endoscopic treatment instrument | |
EP3038474A4 (en) | Nutraceutical combination for prevention and treatment of type 2 diabetes | |
EP3036226A4 (en) | Inhibitors of human 12/15-lipoxygenase | |
EP2712540A4 (en) | Illuminating structure and endoscope | |
EP3060908A4 (en) | Diagnosis and treatment of autoimmune diseases | |
EP3081140A4 (en) | Endoscope treatment instrument | |
GB201602663D0 (en) | Medical instrument and application thereof | |
PL2892556T3 (en) | Compositions and methods relating to the treatment of diseases | |
EP3044229A4 (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
FR2979346B1 (en) | NANOCORPS ANTI-VCAM-1 | |
EP3015864A4 (en) | Biomarkers for the diagnosis and the response to treatment of pancreatic cancer | |
MX2012012744A (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
EP3081183A4 (en) | Treatment instrument and treatment system | |
EP3087940A4 (en) | Medical procedure instrument and medical procedure system | |
EP3045102A4 (en) | Surgical instrument and medical system | |
EP3037032A4 (en) | Light source device and endoscope device |